优化butorphanol-dexmedetomidine的剂量,以管理导管相关的麻醉后膀不适:一个随机试验
Yu-Long Wang1,2, Yan Zhang1, Qiu-Bo Wang2
1Department of Anaesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Scientific reports
|January 6, 2026
概括
德克斯梅德托米丁与布托芬醇结合,在麻醉后恢复期间有效地管理与导管相关的膀不适 (CRBD). 与其他测试方案相比,DLB疗法 (德克斯梅德托米丁0.2μg/kg加布托芬醇10μg/kg) 显示出优异的CRBD缓解,改善了疼痛缓解,降低了镇静风险.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 导管相关的膀不适 (CRBD) 带来了重大风险,并增加了麻醉恢复期间的医疗负担.
- 有效的CRBD管理对于改善患者的治疗结果和减少术后并发症至关重要.
研究的目的:
- 评估三种治疗方案的疗效和安全性,用于管理中度至重度CRBD在经过麻醉恢复的成年患者.
- 为了比较德克斯梅托米丁-苏芬坦尼尔 (DSF),德克斯梅托米丁-丁醇10μg/kg (DLB) 和德克斯梅托米丁-丁醇20μg/kg (DHB) 对CRBD严重程度,血液动力学稳定性,呼吸功能,止痛和镇静的影响.
主要方法:
- 一个单一中心随机对照试验,涉及102名患有中度至重度CRBD的成年患者.
- 患者被分配给接受DSF,DLB或DHB治疗方案.
- 主要结局包括CRBD严重程度得分和响应率;次要结局评估了血液动力稳定性,呼吸抑制,止痛和镇静.
主要成果:
- 所有方案都显著减少了干预后的CRBD (P < 0.001).
- 与DSF (23.5%,P < 0.0001) 相比,DLB疗法在15分钟内显示出明显更高的响应率 (83.3%).
- DLB表现出优越的血液动力学稳定性,下呼吸道抑郁 (13.9%与41.2%在DSF中,P = 0.0103),加强了术后止痛,并减少了过度静止率 (52.8%与82.4%在DSF中,P < 0.05).
结论:
- 将0.2μg/kg的德克斯梅德托米丁与10μg/kg的布托芬醇 (DLB) 结合起来,可以快速有效地缓解CRBD.
- DLB疗法可以改善术后止痛,同时最大限度地减少镇静和呼吸风险.
- 这种组合代表了在麻醉恢复期间管理CRBD的更安全,更有效的策略.
相关概念视频
Depolarizing Blockers: Pharmocokinetics
560
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
560
Parenteral Anesthetics: Overview
570
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
570
Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
Skeletal Muscle Relaxants: Therapeutic Uses
880
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
880
Opioid Analgesics: Synthetic and Semisynthetic Opioids
906
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
906
Drugs for Treatment of Diarrhea-Predominant IBS
618
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
618


